Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial
Authors:
- 15 February 2014
- journal article
- clinical trial
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 138, 83-88
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Randomized Trial of Long-Acting Sustained-Release Naltrexone Implant vs Oral Naltrexone or Placebo for Preventing Relapse to Opioid DependenceArchives of General Psychiatry, 2012
- Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical PracticeThe American Journal of Drug and Alcohol Abuse, 2012
- Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness TrialThe American Journal of Drug and Alcohol Abuse, 2011
- Participant Characteristics and Buprenorphine DoseThe American Journal of Drug and Alcohol Abuse, 2011
- Pharmacological enhancement of naltrexone treatment for opioid dependence: a reviewSubstance Abuse and Rehabilitation, 2011
- Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementationAddictive Behaviors, 2011
- Drug Treatment as HIV Prevention: A Research UpdateJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- CLINICAL STUDY: Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trialAddiction Biology, 2009
- Naltrexone shortened opioid detoxification with buprenorphineDrug and Alcohol Dependence, 1999
- NaltrexoneDrugs, 1988